Kinetics of Vascular Targeted Monoclonal Antibody

E-ISSN： 1875-5704|7|5|428-435

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.7, Iss.5, 2010-12, pp. : 428-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

Edrecolomab (Monoclonal Antibody 17-1A)

By Adkins J.C. Spencer C.M.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 619-626

Adis International

Access to resources Recommend Favorite

Monoclonal antibody–drug conjugates

By Hamann Philip R

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1087-1103

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody “Gold Rush”

Current Medicinal Chemistry, Vol. 14, Iss. 18, 2007-08 ,pp. : 1978-1987

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells

By Mamot Christoph Ritschard Reto Küng Willy Park John W. Herrmann Richard Rochlitz Christoph F.

Journal of Drug Targeting, Vol. 14, Iss. 4, 2006-05 ,pp. : 215-223

Informa Healthcare

Access to resources Recommend Favorite